{
"info": {
"nct_id": "NCT06339060",
"official_title": "An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer vs Cross Therapy.",
"inclusion_criteria": "* A patient will be eligible for inclusion in this study only if ALL of the following criteria apply:\n\n * Histologically confirmed cT2-T4a,N0-N+,M0 resectable esophageal squamous cell carcinoma.\n * Eastern Cooperative Oncology Group (ECOG) performance status 0-1\n * Patients approve and sign the informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* Patients with active autoimmune disease or history of autoimmune disease.\n* Patients who have a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications.\n* Subjects with a history of symptomatic interstitial lung disease.\n* History of allergy to study drug components.\n* Women must not be pregnant or breast-feeding.\n* Men with female partners (WOCBP) that are not willing to use contraception.\n* Patient has received prior chemotherapy, radiotherapy, target therapy and immune therapy for this malignancy or for any other past malignancy.\n* medical conditions that, in the Investigator's opinion, will make the administration of study drug hazardous or obscure the interpretation of toxicity or adverse events",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically confirmed cT2-T4a,N0-N+,M0 resectable esophageal squamous cell carcinoma.",
"criterions": [
{
"exact_snippets": "Histologically confirmed",
"criterion": "histological confirmation",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": true
}
]
},
{
"exact_snippets": "cT2-T4a",
"criterion": "tumor stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2,
"unit": "cT"
},
{
"operator": "<=",
"value": 4,
"unit": "cT"
}
]
}
}
]
},
{
"exact_snippets": "N0-N+",
"criterion": "lymph node involvement",
"requirements": [
{
"requirement_type": "involvement",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N"
},
{
"operator": "<=",
"value": 1,
"unit": "N+"
}
]
}
}
]
},
{
"exact_snippets": "M0",
"criterion": "metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "resectable esophageal squamous cell carcinoma",
"criterion": "resectability",
"requirements": [
{
"requirement_type": "resectability",
"expected_value": true
}
]
},
{
"exact_snippets": "esophageal squamous cell carcinoma",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "esophageal squamous cell carcinoma"
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group (ECOG) performance status 0-1",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0-1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Patients approve and sign the informed consent",
"criterions": [
{
"exact_snippets": "Patients approve and sign the informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "approval",
"expected_value": true
},
{
"requirement_type": "signature",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients with active autoimmune disease or history of autoimmune disease.",
"criterions": [
{
"exact_snippets": "active autoimmune disease",
"criterion": "autoimmune disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": "active"
}
]
},
{
"exact_snippets": "history of autoimmune disease",
"criterion": "autoimmune disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients who have a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications.",
"criterions": [
{
"exact_snippets": "condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications",
"criterion": "condition requiring systemic treatment",
"requirements": [
{
"requirement_type": "treatment type",
"expected_value": [
"corticosteroids",
"immunosuppressive medications"
]
}
]
}
]
},
{
"line": "* Subjects with a history of symptomatic interstitial lung disease.",
"criterions": [
{
"exact_snippets": "history of symptomatic interstitial lung disease",
"criterion": "interstitial lung disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "symptomatic",
"expected_value": true
}
]
}
]
},
{
"line": "* History of allergy to study drug components.",
"criterions": [
{
"exact_snippets": "History of allergy to study drug components.",
"criterion": "allergy to study drug components",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Women must not be pregnant or breast-feeding.",
"criterions": [
{
"exact_snippets": "Women must not be pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "Women must not be ... breast-feeding",
"criterion": "breast-feeding",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
},
{
"line": "* Men with female partners (WOCBP) that are not willing to use contraception.",
"criterions": [
{
"exact_snippets": "Men with female partners (WOCBP) that are not willing to use contraception.",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": false
}
]
}
]
},
{
"line": "* Patient has received prior chemotherapy, radiotherapy, target therapy and immune therapy for this malignancy or for any other past malignancy.",
"criterions": [
{
"exact_snippets": "Patient has received prior chemotherapy",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Patient has received prior ... radiotherapy",
"criterion": "prior radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Patient has received prior ... target therapy",
"criterion": "prior target therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Patient has received prior ... immune therapy",
"criterion": "prior immune therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* medical conditions that, in the Investigator's opinion, will make the administration of study drug hazardous or obscure the interpretation of toxicity or adverse events",
"criterions": [
{
"exact_snippets": "medical conditions that, in the Investigator's opinion, will make the administration of study drug hazardous",
"criterion": "medical conditions",
"requirements": [
{
"requirement_type": "investigator's opinion",
"expected_value": "make the administration of study drug hazardous"
}
]
},
{
"exact_snippets": "medical conditions that, in the Investigator's opinion, will ... obscure the interpretation of toxicity or adverse events",
"criterion": "medical conditions",
"requirements": [
{
"requirement_type": "investigator's opinion",
"expected_value": "obscure the interpretation of toxicity or adverse events"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* A patient will be eligible for inclusion in this study only if ALL of the following criteria apply:",
"criterions": []
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}